Key result
Bone marrow mononuclear stem cell transplantation in a rat cryo-infarct model improved electrical conduction without increasing the inducibility of ventricular tachycardia or fibrillation compared to cryo-infarct controls (34.6% vs 47.2%).
Why the study?
Does bone marrow mononuclear stem cell transplantation improve electrical conduction and affect arrhythmogenicity in a rat cryo-infarct model?
Does bone marrow mononuclear stem cell transplantation improve electrical conduction and affect arrhythmogenicity in a rat cryo-infarct model?
Absolute Event Rate: 34.6% vs 47.2%
Transplantation of bone marrow mononuclear stem cells into the infarct border zone improved electrical conduction without increasing the risk of ventricular arrhythmias in a rat model.
Supports preclinical conduction benefits of stem cell therapy in infarct models; leaves open translation to human arrhythmia risk.
PURPOSE: The arrhythmogenic effect of stem cells transplantation (SCT) in an infarct myocardium is still unknown. We investigated arrhythmogenicity of SCT in rat cryo-infarct model. MATERIALS AND METHODS: In rat cryo-infarct model, bone marrow mononuclear stem cells (MNSC, 1 x 10(7) cells) were transplanted into the infarct border zone (BZ) of the LV epicardium. We compared the optical mapping and inducibility of ventricular tachycardia/fibrillation (VT/VF) among normal (n=5), cryo-infarct (n=6), and SCT rats (n=6). RESULTS: The VT/VF inducibility was higher in the cryo- infarct (47.2%, p=0.001) and SCT groups (34.6%, p=0.01) than in the normal group (12.8%). The induced VT/VF episodes persisted for more than 2 minutes in 4.3%, 26.4% and 17.3% in the normal, cryo-infarct and SCT group, respectively. In the SCT group, the action potential duration at 70% was shorter at the SCT site than the BZ during SR (75.2 +/- 8.1 vs. 145.6 +/- 4.4 ms, p=0.001) and VT (78.2 +/- 13.0 vs. 125.7 +/- 21.0 ms, p= 0.001). Conduction block was observed at the SCT site and BZ during VT. However, no reentry or ectopic foci were observed around the SCT sites. CONCLUSION: The electrical conduction was improved by SCT without evidence of augmentation of arrhythmia in the rat cryo-infarct model.
No takes yet. Share an insight, caveat, or question.
Joung et al. (2007) studied Myocardial Infarction (n=17). Bone marrow mononuclear stem cells (MNSC) vs. Saline (cryo-infarction group) and normal rats was evaluated on Inducibility of ventricular tachycardia/fibrillation (VT/VF). Bone marrow mononuclear stem cell transplantation in a rat cryo-infarct model improved electrical conduction without increasing the inducibility of ventricular tachycardia or fibrillation compared to cryo-infarct controls (34.6% vs 47.2%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: